Filing Flows › Angiodynamics (ANGO) › How it makes money
How Angiodynamics (ANGO) makes money
Angiodynamics (ANGO) made $80.9M of revenue in the first quarter fiscal 2027 (Q1 FY27), +7% from a year earlier. Med Device brought in $41.0M (51%); Med Tech brought in $39.9M (49%).
Drawing the Sankey…
Revenue by segment, Q1 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Med Device | $41.0M | 50.7% | — | +1% |
| Med Tech | $39.9M | 49.3% | — | +13% |
Where each dollar of revenue goes
| Line | Q1 FY27 | % of revenue |
|---|---|---|
| Revenue | $80.9M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 FY27 | $80.9M | +7% |
| Q4 FY26 | $86.6M | +8% |
| Q3 FY26 | $78.4M | +9% |
| Q2 FY26 | $79.4M | +9% |
| Q1 FY26 | $75.7M | +12% |
| Q4 FY25 | $80.2M | +13% |
| Q3 FY25 | $72.0M | -4% |
From Angiodynamics' 10-Q filed Oct 8, 2026 (on EDGAR).
Questions
How does Angiodynamics make money?
Angiodynamics (ANGO) made $80.9M of revenue in the first quarter fiscal 2027 (Q1 FY27), +7% from a year earlier. Med Device brought in $41.0M (51%); Med Tech brought in $39.9M (49%).
What is Angiodynamics' biggest business?
Med Device: $41.0M in the first quarter fiscal 2027, 51% of revenue, +1% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.